- •Foreword
- •Preface
- •List of Contributors
- •Acknowledgments
- •Dedication
- •In Memorium
- •DEFINITIONS
- •EPIDEMIOLOGIC AND SOCIOECONOMIC ASPECTS OF THE GLAUCOMAS
- •RISK FACTORS
- •CLASSIFICATION OF THE GLAUCOMAS
- •REFERENCES
- •Aqueous humor formation
- •FUNCTION OF AQUEOUS HUMOR
- •ANATOMY OF THE CILIARY BODY
- •STRUCTURE
- •ULTRASTRUCTURE OF THE CILIARY PROCESSES
- •VASCULAR SUPPLY
- •MECHANISM OF AQUEOUS FORMATION
- •ULTRAFILTRATION
- •ACTIVE TRANSPORT
- •DIFFUSION
- •CHEMICAL COMPOSITION OF THE AQUEOUS HUMOR
- •THE BLOOD–AQUEOUS BARRIER
- •PRESSURE-DEPENDENT TECHNIQUES
- •Tonography
- •Suction cup
- •Perfusion
- •TRACER METHODS
- •Photogrammetry
- •Radiolabeled isotopes
- •Fluorescein
- •Fluoresceinated dextrans
- •Paraminohippurate
- •Iodide
- •FACTORS AFFECTING AQUEOUS HUMOR FORMATION
- •DIURNAL VARIATION
- •INTRAOCULAR PRESSURE/PSEUDOFACILITY
- •BLOOD FLOW TO THE CILIARY BODY
- •NEURAL CONTROL
- •HORMONAL EFFECTS
- •INTRACELLULAR REGULATORS
- •CLINICAL ASPECTS OF AQUEOUS HUMOR FORMATION
- •CLINICAL CONDITIONS
- •PHARMACOLOGIC AGENTS
- •SURGERY
- •REFERENCES
- •PHYSIOLOGY ISSUES UNIQUE TO THE CONVENTIONAL AQUEOUS OUTFLOW SYSTEM
- •FUNCTIONS OF THE CONVENTIONAL AQUEOUS OUTFLOW SYSTEM
- •ANATOMY OF THE CONVENTIONAL OUTFLOW SYSTEM
- •SCHWALBE’S LINE
- •SCLERAL SPUR
- •TRABECULAR MESHWORK TISSUES
- •Uveal meshwork
- •Corneoscleral meshwork
- •Uveal and corneoscleral meshwork ultrastructure
- •Juxtacanalicular space and cells
- •SCHLEMM’S CANAL
- •Overview
- •Schlemm’s canal inner wall endothelium
- •Glycocalyx
- •Distending cells that form invaginations or pseudovacuoles, ‘giant vacuoles’
- •Schlemm’s canal endothelium pores
- •Sonderman’s canals invaginate into the trabecular meshwork
- •Septa
- •Schlemm’s canal valves spanning across Schlemm’s canal
- •Herniations or protrusions of Schlemm’s canal inner wall
- •Collector channels, aqueous veins and episcleral veins
- •RESISTANCE SITES IN THE AQUEOUS OUTFLOW SYSTEM
- •JUXTACANALICULAR SPACE RESISTANCE
- •SCHLEMM’S CANAL ENDOTHELIUM RESISTANCE
- •PRINCIPLES OF BIOMECHANICS AS A METHODOLOGY TO IDENTIFY TISSUE RESISTANCE
- •TISSUE LOADING STUDIES
- •BOUNDARY CONDITIONS
- •EVIDENCE FROM EXPERIMENTAL MICROSURGERY
- •AQUEOUS OUTFLOW PHYSIOLOGY: PASSIVE AND DYNAMIC FLOW MODELS
- •THE AQUEOUS OUTFLOW SYSTEM AS A PASSIVE FILTER
- •THE AQUEOUS OUTFLOW SYSTEM AS A DYNAMIC MECHANICAL PUMP
- •EXTRINSIC PRESSURE REGULATION MECHANISMS
- •UVEOSCLERAL FLOW
- •METHODS FOR MEASURING FACILITY OF OUTFLOW
- •FACILITY OF OUTFLOW CALCULATIONS
- •Tonography
- •Perfusion
- •Suction cup
- •FACILITY OF OUTFLOW AND ITS CLINICAL IMPLICATIONS
- •FACTORS AFFECTING THE FACILITY OF OUTFLOW
- •HORMONES
- •CILIARY MUSCLE TONE
- •DRUGS
- •SURGICAL THERAPY
- •DIURNAL FLUCTUATION
- •GLAUCOMA
- •EPISCLERAL VENOUS PRESSURE
- •REFERENCES
- •Intraocular pressure
- •INSTRUMENTS FOR MEASURING INTRAOCULAR PRESSURE
- •APPLANATION INSTRUMENTS
- •Goldmann tonometer
- •Perkins tonometer
- •Draeger tonometer
- •MacKay-Marg and Tono-Pen™ tonometers
- •Pneumatic tonometer
- •Non-contact tonometer
- •The Ocuton™ tonometer
- •Maklakow tonometer
- •INDENTATION INSTRUMENTS
- •Schiøtz tonometer
- •Electronic Schiøtz tonometer
- •Impact–rebound tonometer
- •Transpalpebral tonometry
- •DYNAMIC CONTOUR TONOMETRY
- •CONTINUOUS MONITORING OF INTRAOCULAR PRESSURE
- •SUMMARY OF TONOMETRY
- •DISTRIBUTION OF INTRAOCULAR PRESSURE IN THE GENERAL POPULATION
- •FACTORS THAT INFLUENCE INTRAOCULAR PRESSURE
- •RACE
- •HEREDITY
- •DIURNAL VARIATION
- •SEASONAL VARIATION
- •CARDIOVASCULAR FACTORS
- •EXERCISE
- •WIND INSTRUMENT PLAYING
- •LIFESTYLE
- •POSTURAL CHANGES
- •NEURAL FACTORS
- •PSYCHIATRIC DISORDERS
- •HORMONAL FACTORS
- •REFRACTIVE ERROR
- •FOODS AND DRUGS
- •MISCELLANEOUS
- •EYE MOVEMENTS
- •EYELID CLOSURE
- •INFLAMMATION
- •SURGERY
- •REFERENCES
- •Gonioscopic anatomy
- •GROSS ANATOMY
- •ANATOMIC FEATURES OF NORMAL EYES
- •GONIOSCOPIC ANATOMY AND MICROSCOPIC INTERPRETATION
- •PUPIL AND IRIS
- •CILIARY BODY, IRIS PROCESSES, AND SYNECHIAE
- •SCLERAL SPUR
- •SCHWALBE’S LINE
- •TRABECULAR MESHWORK AND TRABECULAR PIGMENT BAND
- •GONIOSCOPIC APPEARANCE
- •REFERENCES
- •Methods of gonioscopy
- •DEFINITION
- •METHODS OF GONIOSCOPY
- •EQUIPMENT
- •Goldmann and Zeiss lenses (indirect method)
- •Koeppe lens (direct method)
- •TECHNIQUE
- •Indirect gonioscopic lenses
- •Indentation (compression) gonioscopy
- •Direct gonioscopic lens
- •REFERENCES
- •GRADING OF CHAMBER ANGLE
- •DIAGRAMMING ANGLE WIDTH, SYNECHIAE, AND PIGMENTATION
- •TRABECULAR PIGMENT BAND
- •SPAETH CLASSIFICATION
- •STEP 4: TRABECULAR MESHWORK PIGMENTATION
- •EXAMPLES
- •DIFFICULTIES AND ARTIFACTS IN GONIOSCOPY
- •CLINICAL USEFULNESS OF GONIOSCOPY
- •AID IN DIAGNOSIS OF TYPE OF GLAUCOMA
- •EVALUATION OF SYMPTOMS
- •USE OF DRUGS
- •POSTOPERATIVE EXAMINATIONS
- •CONDITIONS OTHER THAN GLAUCOMA
- •SUMMARY OF IMPORTANT GONIOSCOPIC TECHNIQUES
- •REFERENCES
- •APPENDIX
- •Visual field theory and methods
- •THE NORMAL VISUAL FIELD
- •VISUAL ACUITY VERSUS VISUAL FIELD
- •TERMINOLOGY AND DEFINITIONS
- •THEORY OF VISUAL FIELD TESTING
- •KINETIC PERIMETRY
- •STATIC PERIMETRY
- •THRESHOLD-RELATED TESTING
- •ZONE TESTING
- •SCREENING TESTS
- •OTHER STATIC TESTING TECHNIQUES
- •THE FUTURE OF VISUAL FIELD TESTING
- •COMBINED STATIC AND KINETIC PERIMETRY
- •REFERENCES
- •PATIENT VARIABLES
- •FIXATION
- •RELIABILITY
- •OCULAR VARIABLES
- •PUPIL SIZE
- •MEDIA CLARITY
- •REFRACTIVE CORRECTION
- •TESTING VARIABLES
- •TECHNICIAN
- •BACKGROUND ILLUMINATION
- •STIMULUS SIZE AND INTENSITY
- •STIMULUS EXPOSURE TIME
- •AREA TESTED
- •EQUIPMENT AND TECHNIQUES
- •GENERAL PRINCIPLES
- •TANGENT SCREEN
- •BOWL PERIMETRY
- •Preparing the patient
- •Technique of computerized bowl perimetry
- •REFERENCES
- •Visual field interpretation
- •GLAUCOMATOUS CHANGES IN THE VISUAL FIELD
- •ANATOMY OF VISUAL FIELD DEFECTS
- •TYPES OF VISUAL FIELD LOSS
- •Generalized loss
- •Localized defects (scotomata)
- •GLAUCOMATOUS VISUAL FIELD DEFECTS
- •Generalized depression
- •Irregularity of the visual field
- •Nasal step or depression
- •Temporal step or depression
- •Enlargement of the blind spot
- •Isolated paracentral scotomata
- •Arcuate defects (nerve fiber bundle defects)
- •End-stage defects
- •Central and temporal islands
- •Reversal of visual field defects
- •ANALYSIS OF VISUAL FIELD LOSS
- •CHRONIC OPEN-ANGLE GLAUCOMA
- •ANGLE-CLOSURE GLAUCOMA
- •OTHER CAUSES
- •ESTERMAN DISABILITY RATING
- •ANALYSIS OF COMPUTERIZED STATIC PERIMETRY
- •RELIABILITY INDEXES
- •False-positive and false-negative responses
- •Fixation reliability
- •FLUCTUATION
- •Short-term fluctuation
- •Long-term fluctuation
- •GLOBAL INDEXES
- •Mean sensitivity
- •Mean deviation or defect
- •Standard deviation or variance
- •GRAPHIC PLOTS
- •AREA OF THE VISUAL FIELD TO BE TESTED
- •LONG-TERM ANALYSIS
- •DETERMINATION OF NORMAL VISUAL FIELD
- •DEVIATION FROM NORMAL VALUES
- •Graphic plot of points varying from normal
- •Global indexes
- •Comparison with the other eye
- •Localized variation within the visual field
- •RECOGNITION OF CHANGE
- •QUANTIFYING VISUAL FIELD CHANGE
- •THE FUTURE OF COMPUTERIZED PERIMETRY
- •REFERENCES
- •Other psychophysical tests
- •INTRODUCTION
- •COLOR VISION AND SHORT-WAVELENGTH AUTOMATED PERIMETRY
- •FREQUENCY-DOUBLING PERIMETRY
- •OTHER PSYCHOPHYSICAL TESTS
- •HIGH-PASS RESOLUTION PERIMETRY
- •MOTION DETECTION PERIMETRY
- •ELECTROPHYSIOLOGY
- •The electroretinogram (ERG)
- •The pattern electroretinogram (PERG)
- •The multifocal electroretinogram (mfERG)
- •The multifocal visual-evoked potential (mfVEP)
- •REFERENCES
- •ANATOMY OF THE OPTIC NERVE HEAD
- •WHERE ARE THE GANGLION CELLS INJURED?
- •WHAT INJURES GANGLION CELLS?
- •Ganglion Cell Susceptibility
- •Connective tissue structures within the optic nerve head
- •Vascular nutrition of the optic disc
- •REFERENCES
- •CLINICAL TECHNIQUES OF EVALUATION
- •OPTIC DISC CHANGES IN GLAUCOMA
- •INTRAPAPILLARY DISC CHANGES
- •Optic disc size
- •Optic disc shape
- •Neuroretinal rim size (NRR)
- •Neuroretinal rim shape
- •Optic cup size in relation to optic disc size
- •Optic cup configuration and depth
- •Cup:disc ratios
- •Position of central retinal vessels and branches
- •PERIPAPILLARY DISC CHANGES
- •Optic disc hemorrhages
- •Nerve fiber layer defects
- •Diameter of retinal arterioles
- •Peripapillary choroidal atrophy
- •PATTERNS OF OPTIC NERVE CHANGES AND SUBTYPES OF GLAUCOMA
- •HIGH MYOPIA DISC PATTERN
- •FOCAL NORMAL-PRESSURE PATTERN (FOCAL ISCHEMIC)
- •AGE-RELATED ATROPHIC PRIMARY OPEN-ANGLE GLAUCOMA PATTERN (SENILE SCLEROTIC)
- •JUVENILE OPEN-ANGLE GLAUCOMA PATTERN
- •PRIMARY OPEN-ANGLE GLAUCOMA PATTERN (GENERALIZED ENLARGEMENT)
- •REFERENCES
- •Optic nerve imaging
- •CONFOCAL SCANNING LASER OPHTHALMOSCOPY (CSLO)
- •HEIDELBERG RETINA TOMOGRAPHY (HRT)
- •Components of the HRT report
- •Evaluating scan quality
- •Strengths and limitations
- •New developments
- •Testing from the patient’s perspective
- •OPTICAL COHERENCE TOMOGRAPHY (OCT)
- •DIFFERENT SCANNING MODALITIES
- •Peripapillary scan
- •Macular scan
- •ONH scan
- •Fast scans
- •COMPONENTS OF THE OCT REPORT
- •RNFL thickness average analysis
- •Macular analysis
- •Optic nerve head analysis
- •QUALITY ASSESSMENT
- •STRENGTHS AND LIMITATIONS
- •TESTING FROM THE PATIENT’S PERSPECTIVE
- •LONGITUDINAL EVALUATIONS
- •SCANNING LASER POLARIMETRY
- •Components of the GDX report
- •Quality assessment
- •Strengths and limitations
- •Testing from the patient’s perspective
- •CONCLUSIONS
- •REFERENCES
- •Primary angle-closure glaucoma
- •HISTORICAL REVIEW AND CLASSIFICATIONS
- •CLASSIFICATIONS OF ANGLE-CLOSURE DISEASE
- •TWENTY-FIRST CENTURY CONSENSUS CLASSIFICATION
- •CLARIFICATIONS AND COMMENTARY
- •PRESENTATIONS OF PRIMARY ANGLE-CLOSURE DISEASE
- •NEW IMAGING TECHNOLOGIES
- •CLASSIFICATION BY MECHANISMS IN THE ANTERIOR SEGMENT
- •PUPILLARY BLOCK GLAUCOMA
- •Epidemiologic studies
- •Demographic risk factors
- •Gender
- •Heredity
- •Refractive error
- •Miscellaneous factors
- •Ocular risk factors and mechanisms
- •Iris bowing and lens–iris channel
- •Provocative tests
- •Clinical presentations of acute PACG with pupillary block
- •Signs and symptoms
- •Clinical examination
- •Treatment of acute PACG
- •Medical management of acute PACG
- •Slit-lamp maneuvers in management of acute PACG
- •Laser interventions for acute PACG
- •Surgical management of PACG
- •Management of the fellow eye
- •Sequelae of acute PACG
- •Correlating older and newer terminologies for angle closure
- •PLATEAU IRIS
- •Plateau iris configuration
- •Plateau iris syndrome
- •Pseudoplateau iris (cysts of the iris and ciliary body)
- •PHACOMORPHIC GLAUCOMA
- •Intumescent and swollen lens
- •REFERENCES
- •OVERVIEW OF TERMS AND MECHANISMS
- •ANTERIOR PULLING MECHANISM
- •NEOVASCULAR GLAUCOMA
- •Histopathology
- •Pathogenesis
- •Conditions and diseases commonly associated with neovascular glaucoma
- •Diabetes mellitus
- •Central retinal vein occlusion
- •Carotid occlusive disease
- •Ocular ischemic syndrome
- •Central retinal artery occlusion
- •Miscellaneous
- •Clinical presentation
- •Treatment
- •IRIDOCORNEAL ENDOTHELIAL SYNDROME
- •Histopathology
- •Pathogenesis
- •Clinical presentation
- •Progressive (essential) iris atrophy
- •Chandler’s syndrome
- •Cogan-Reese syndrome
- •Treatment
- •POSTERIOR POLYMORPHOUS DYSTROPHY
- •Histopathology
- •Pathogenesis
- •Clinical presentation
- •Treatment
- •EPITHELIAL DOWNGROWTH
- •Pathophysiology
- •Histopathology
- •Clinical presentation
- •Treatment
- •FIBROVASCULAR INGROWTH
- •FLAT ANTERIOR CHAMBER
- •INFLAMMATION
- •PENETRATING KERATOPLASTY
- •IRIDOSCHISIS
- •ANIRIDIA
- •POSTERIOR PUSHING (OR ROTATIONAL) MECHANISM
- •CILIARY BLOCK GLAUCOMA (AQUEOUS MISDIRECTION OR MALIGNANT GLAUCOMA)
- •INTRAOCULAR TUMORS
- •NANOPHTHALMOS
- •SUPRACHOROIDAL HEMORRHAGE
- •POSTERIOR SEGMENT INFLAMMATORY DISEASE
- •Treatment
- •CENTRAL RETINAL VEIN OCCLUSION
- •SCLERAL BUCKLING PROCEDURE
- •PANRETINAL PHOTOCOAGULATION
- •RETINOPATHY OF PREMATURITY
- •PUPILLARY BLOCK MECHANISMS
- •Secondary pupillary block glaucoma: iris–lens adhesions
- •Dislocated and subluxed lens
- •Ectopia lentis
- •Microspherophakia
- •REFERENCES
- •Primary open angle glaucoma
- •EPIDEMIOLOGY
- •PREVALENCE
- •PATHOPHYSIOLOGY
- •DIMINISHED AQUEOUS HUMOR OUTFLOW FACILITY
- •Altered corticosteroid metabolism
- •Dysfunctional adrenergic control
- •Abnormal immunologic processes
- •Oxidative damage
- •Other toxic influences
- •OPTIC NERVE CUPPING AND ATROPHY
- •CLINICAL FEATURES
- •FINDINGS
- •DIFFERENTIAL DIAGNOSIS
- •TREATMENT
- •INDICATIONS
- •GOALS
- •Target pressure
- •TYPES OF TREATMENT
- •PROGNOSIS
- •THE GLAUCOMA SUSPECT AND OCULAR HYPERTENSION
- •EPIDEMIOLOGY OF OCULAR HYPERTENSION
- •RISK FACTORS FOR DEVELOPMENT OF OPEN-ANGLE GLAUCOMA
- •TREATMENT
- •NORMAL-TENSION GLAUCOMA
- •PATHOGENESIS
- •CLINICAL FEATURES
- •DIFFERENTIAL DIAGNOSIS
- •WORK-UP
- •TREATMENT
- •REFERENCES
- •Secondary open angle glaucoma
- •PIGMENTARY GLAUCOMA
- •EXFOLIATION SYNDROME (PSEUDOEXFOLIATION SYNDROME)
- •CORTICOSTEROID GLAUCOMA
- •LENS-INDUCED GLAUCOMA
- •PHACOLYTIC GLAUCOMA
- •LENS-PARTICLE GLAUCOMA
- •PHACOANAPHYLAXIS
- •GLAUCOMA AFTER CATARACT SURGERY
- •GLAUCOMA FROM VISCOELASTIC SUBSTANCES
- •GLAUCOMA WITH PIGMENT DISPERSION FROM INTRAOCULAR LENSES
- •UVEITIS-GLAUCOMA-HYPHEMA SYNDROME
- •GLAUCOMA FROM VITREOUS IN THE ANTERIOR CHAMBER
- •GLAUCOMA AFTER TRAUMA
- •CHEMICAL BURNS
- •ELECTRIC SHOCK
- •RADIATION
- •PENETRATING INJURIES
- •CONTUSION INJURIES
- •GLAUCOMA ASSOCIATED WITH INTRAOCULAR HEMORRHAGE
- •GHOST-CELL GLAUCOMA
- •HEMOLYTIC GLAUCOMA
- •HEMOSIDEROSIS
- •HYPHEMA
- •RETINAL DETACHMENT AND GLAUCOMA
- •SCHWARTZ SYNDROME
- •GLAUCOMA AFTER VITRECTOMY
- •GLAUCOMA WITH UVEITIS
- •FUCHS’ HETEROCHROMIC IRIDOCYCLITIS
- •GLAUCOMATOCYCLITIC CRISIS
- •HERPES SIMPLEX
- •HERPES ZOSTER
- •SARCOIDOSIS
- •JUVENILE RHEUMATOID ARTHRITIS
- •SYPHILIS
- •INTRAOCULAR TUMORS AND GLAUCOMA
- •AMYLOIDOSIS
- •ELEVATED EPISCLERAL VENOUS PRESSURE
- •SUPERIOR VENA CAVA OBSTRUCTIONS
- •THYROID EYE DISEASE
- •ARTERIOVENOUS FISTULAS
- •STURGE-WEBER SYNDROME
- •IDIOPATHIC ELEVATIONS
- •REFERENCES
- •TERMINOLOGY
- •CLASSIFICATION
- •SYNDROME CLASSIFICATION
- •PRIMARY GLAUCOMA
- •CLINICAL ANATOMIC CLASSIFICATION
- •Isolated trabeculodysgenesis
- •Iridodysgenesis
- •Anterior stromal defects
- •Structural iris defects
- •Corneodysgenesis
- •CLINICAL PRESENTATION
- •EXAMINATION
- •Office examination
- •Examination under anesthesia
- •Intraocular pressure measurement
- •Corneal measurements: diameter and central thickness
- •Axial length measurement
- •Gonioscopy
- •Ophthalmoscopy
- •Cycloplegic refraction
- •Systemic evaluation
- •PRIMARY CONGENITAL GLAUCOMA
- •INCIDENCE
- •GENETICS AND HEREDITY
- •PATHOPHYSIOLOGY
- •DIFFERENTIAL DIAGNOSIS
- •Other glaucomas
- •Other causes of corneal enlargement or clouding
- •Other causes of epiphora or photophobia
- •Other optic nerve abnormalities
- •MANAGEMENT
- •Preoperative management
- •Initial surgery
- •Follow-up evaluations
- •Filtering surgery
- •Synthetic drainage devices
- •Cyclodestructive procedures
- •Long-term follow-up, management, and prognosis
- •Late developing primary congenital glaucoma
- •GLAUCOMA ASSOCIATED WITH OTHER CONGENITAL ANOMALIES
- •FAMILIAL HYPOPLASIA OF THE IRIS WITH GLAUCOMA
- •DEVELOPMENTAL GLAUCOMA WITH ANOMALOUS SUPERFICIAL IRIS VESSELS
- •ANIRIDIA
- •STURGE-WEBER SYNDROME (ENCEPHALOFACIAL ANGIOMATOSIS, ENCEPHALOTRIGEMINAL ANGIOMATOSIS)
- •NEUROFIBROMATOSIS (VON RECKLINGHAUSEN’S DISEASE)
- •PIERRE ROBIN AND STICKLER SYNDROMES
- •SKELETAL DYSPLASTIC SYNDROMES
- •CORNEODYSGENESIS
- •Axenfeld’s anomaly
- •Rieger’s anomaly and syndrome
- •PETER’S ANOMALY
- •LOWE SYNDROME (OCULOCEREBRORENAL SYNDROME)
- •MICROCORNEA SYNDROMES
- •RUBELLA
- •CHROMOSOME ABNORMALITIES
- •BROAD THUMB SYNDROME (RUBENSTEIN–TAYBI SYNDROME)
- •SECONDARY GLAUCOMA IN INFANTS
- •PERSISTENT FETAL VASCULATURE (PERSISTENT HYPERPLASITIC PRIMARY VITREOUS)
- •RETINOPATHY OF PREMATURITY (RETROLENTAL FIBROPLASIAS)
- •LENS-RELATED GLAUCOMAS
- •Aphakic pediatric glaucoma
- •Subluxation and pupillary block
- •Marfan syndrome
- •Homocystinuria
- •Spherophakia and pupillary block
- •Weill-Marchesani and GEMSS syndromes
- •TUMORS
- •Retinoblastoma
- •Juvenile xanthogranuloma
- •INFLAMMATION
- •Juvenile rheumatoid arthritis
- •STEROID GLAUCOMA IN CHILDREN
- •NEOVASCULAR GLAUCOMA
- •TRAUMA
- •REFERENCES
- •Genetics of glaucoma
- •BASIC GENETICS
- •GENETIC NOMENCLATURE
- •PRIMARY OPEN-ANGLE, NORMAL-TENSION, AND JUVENILE-ONSET OPEN-ANGLE GLAUCOMA
- •TIGR/MYOCILIN
- •OPTINEURIN
- •OTHER GENES IN OPEN-ANGLE GLAUCOMA
- •EXFOLIATION SYNDROME AND GLAUCOMA
- •GLAUCOMA ASSOCIATED WITH DEVELOPMENTAL DISORDERS
- •PRIMARY CONGENITAL GLAUCOMA
- •AXENFELD-RIEGER ANOMALY
- •ANIRIDIA
- •NAIL PATELLA SYNDROME
- •RENAL TUBULAR ACIDOSIS
- •SUMMARY
- •REFERENCES
- •DIAGNOSIS
- •IDENTIFYING GLAUCOMA SUSPECTS
- •DETERMINING ADEQUACY OF TREATMENT
- •TREATMENT FOLLOW-UP
- •DOCUMENTATION OF PROGRESS
- •PATIENT EDUCATION
- •EFFECTIVE JUDGMENT
- •REFERENCES
- •TARGET PRESSURE
- •MEDICAL THERAPY
- •ADVANTAGES
- •DISADVANTAGES
- •SURGICAL THERAPY
- •ADVANTAGES
- •DISADVANTAGES
- •BASIC PHARMACOLOGY
- •BIOAVAILABILITY OF TOPICAL OCULAR MEDICATION
- •TEAR FILM
- •CORNEAL BARRIERS
- •DRUG FORMULATION
- •DRUG ELIMINATION
- •COMPLIANCE
- •GENERAL SUGGESTIONS FOR MEDICAL TREATMENT OF GLAUCOMA
- •ESTABLISH A TARGET PRESSURE
- •ADJUST THE TREATMENT PROGRAM TO THE PATIENT AND HIS OR HER LIFESTYLE
- •WHEN THERAPY IS INEFFECTIVE, SUBSTITUTE RATHER THAN ADD DRUGS
- •CONTINUALLY MONITOR THE TARGET PRESSURE
- •ASK ABOUT AND MONITOR OCULAR AND SYSTEMIC SIDE EFFECTS
- •SIMPLIFY AND REDUCE TREATMENT WHEN POSSIBLE
- •TEACH PATIENTS THE PROPER TECHNIQUE FOR INSTILLING EYEDROPS
- •PROVIDE WRITTEN INSTRUCTIONS
- •COMMUNICATE WITH THE PATIENT’S FAMILY PHYSICIAN
- •ASK ABOUT PROBLEMS WITH THE MEDICAL REGIMEN
- •CONSIDER DEFAULTING AS AN EXPLANATION FOR THE FAILURE OF MEDICAL TREATMENT
- •EDUCATE PATIENTS ABOUT THEIR ILLNESS AND ITS TREATMENT
- •STOP TREATMENT PERIODICALLY TO DETERMINE CONTINUING EFFECTIVENESS
- •MEASURE INTRAOCULAR PRESSURE AT DIFFERENT TIMES OF THE DAY AND AT DIFFERENT INTERVALS AFTER THE LAST ADMINISTRATION OF MEDICATION
- •RECOMMEND COMPARISON SHOPPING FOR MEDICATIONS
- •SUMMARY
- •REFERENCES
- •Prostaglandins
- •MECHANISM OF ACTION
- •DRUGS IN CLINICAL USE
- •LATANOPROST (XALATAN, PHXA41)
- •BIMATOPROST
- •TRAVOPROST
- •FIXED COMBINATION AGENTS
- •SIDE EFFECTS
- •SUGGESTIONS FOR USE
- •REFERENCES
- •MECHANISM(S) OF ACTION
- •EPINEPHRINE
- •DIPIVEFRIN
- •NOREPINEPHRINE
- •Phenylephrine
- •Clonidine
- •Apraclonidine
- •Brimonidine
- •Isoproterenol
- •Salbutamol
- •Others
- •DOPAMINERGIC AGONISTS
- •ADRENERGIC POTENTIATORS
- •MONOAMINE OXIDASE AND CATECHOL O-METHYLTRANSFERASE INHIBITORS
- •6-HYDROXYDOPAMINE
- •PROTRIPTYLINE
- •GUANETHIDINE (ISMELIN)
- •NONADRENERGIC ACTIVATORS OF ADENYLATE CYCLASE
- •DRUGS IN CLINICAL USE
- •Epinephrine (Eppy, Epinal, Epifrin, and generics)
- •Dipivefrin (Propine and generics)
- •Suggestions for use
- •Side effects
- •Clonidine
- •Prophylaxis in anterior segment laser surgery
- •Argon laser trabeculoplasty
- •Laser iridotomy
- •Nd:YAG laser posterior capsulotomy
- •Management of acute pressure rises
- •Management of open-angle and other chronic glaucomas
- •Combination therapy
- •Side effects
- •Suggestions for use
- •SUMMARY
- •REFERENCES
- •Adrenergic antagonists
- •MECHANISM OF ACTION
- •DRUGS IN CLINICAL USE
- •TIMOLOL MALEATE
- •TIMOLOL HEMIHYDRATE
- •BETAXOLOL
- •LEVOBUNOLOL
- •CARTEOLOL
- •METIPRANOLOL
- •PROPRANOLOL
- •ATENOLOL
- •PINDOLOL
- •NADOLOL
- •METAPROLOL
- •LABETOLOL
- •SUGGESTIONS FOR USE
- •OPEN-ANGLE GLAUCOMA
- •ANGLE-CLOSURE GLAUCOMA
- •SECONDARY GLAUCOMA
- •GLAUCOMA IN CHILDREN
- •BLOOD FLOW AND NEUROPROTECTION
- •SIDE EFFECTS
- •OCULAR
- •SYSTEMIC
- •OTHER ADRENERGIC ANTAGONISTS
- •Thymoxamine
- •Dapiprazole
- •Bunazosin
- •Prazosin
- •Others
- •REFERENCES
- •Carbonic anhydrase inhibitors
- •MECHANISM OF ACTION
- •DIRECT EFFECT ON AQUEOUS HUMOR FORMATION
- •INDIRECT EFFECT ON AQUEOUS HUMOR FORMATION
- •DRUGS IN CLINICAL USE
- •TOPICAL CARBONIC ANHYDRASE INHIBITORS
- •Dorzolamide
- •Brinzolamide
- •SYSTEMIC CARBONIC ANHYDRASE INHIBITORS
- •Acetazolamide
- •Methazolamide
- •Ethoxzolamide
- •Dichlorphenamide
- •SIDE EFFECTS
- •TOPICAL CARBONIC ANHYDRASE INHIBITORS
- •ORAL CARBONIC ANHYDRASE INHIBITORS
- •CONTRAINDICATIONS
- •Acidosis and sickling of red blood cells
- •Other severe symptoms
- •Retinal-choroidal blood flow and neuroprotection
- •SUGGESTIONS FOR USE
- •ANGLE-CLOSURE GLAUCOMA
- •OPEN-ANGLE GLAUCOMA
- •SECONDARY GLAUCOMA
- •INFANTILE AND JUVENILE GLAUCOMA
- •OTHER USES
- •REFERENCES
- •Cholinergic drugs
- •MECHANISMS OF ACTION
- •ANGLE-CLOSURE GLAUCOMA
- •OPEN-ANGLE GLAUCOMA
- •DRUGS IN CLINICAL USE
- •DIRECT-ACTING CHOLINERGIC AGENTS
- •Acetylcholine
- •Pilocarpine
- •Alternative drug delivery systems
- •Methacholine (Mecholyl)
- •Carbachol
- •Aceclidine (Glaucostat)
- •INDIRECT (ANTICHOLINESTERASE) AGENTS
- •Echothiophate iodide (phospholine iodide)
- •Demecarium bromide (Humorsol, Tosmilen)
- •Isoflurophate (Floropryl, di-isopropyl fluorophosphate, Dyflos)
- •Physostigmine (eserine)
- •Neostigmine (prostigmine)
- •SIDE EFFECTS
- •OCULAR
- •SYSTEMIC
- •SUGGESTIONS FOR USE
- •EXAMINATION
- •CONTRAINDICATIONS
- •REFERENCES
- •Hyperosmotic agents
- •MECHANISMS OF ACTION
- •DRUGS IN CLINICAL USE
- •ORAL AGENTS
- •Glycerol
- •Isosorbide
- •Ethyl alcohol
- •INTRAVENOUS AGENTS
- •Mannitol
- •Urea
- •SIDE EFFECTS
- •SUGGESTIONS FOR CLINICAL USE
- •ANGLE-CLOSURE GLAUCOMA
- •SECONDARY GLAUCOMA
- •CILIARY BLOCK (MALIGNANT) GLAUCOMA
- •TOPICAL HYPEROSMOTIC AGENTS
- •OTHER
- •REFERENCES
- •General aspects of laser therapy
- •GENERAL ASPECTS OF LASER THERAPY
- •TISSUE EFFECTS OF LASER
- •THERMAL EFFECTS (PHOTOCOAGULATION, PHOTOVAPORIZATION)
- •PHOTODISRUPTION
- •PHOTOABLATION
- •PHOTOCHEMICAL EFFECTS
- •GENERAL PREPARATION OF THE PATIENT
- •BASIC LASER SAFETY
- •REFERENCES
- •LASER PERIPHERAL IRIDOTOMY
- •INDICATIONS
- •TYPES OF LASER
- •GENERAL PREPARATION
- •ND:YAG LASER IRIDOTOMY
- •ARGON OR SOLID-STATE LASER IRIDOTOMY
- •LIGHT BROWN IRIS
- •Dark brown iris
- •Light blue iris
- •COMPLICATIONS OF LASER IRIDOTOMY
- •Iritis
- •Pressure elevation
- •Cataract
- •Hyphema
- •Corneal epithelial injury
- •Endothelial damage
- •Corneal stroma
- •Failure to perforate
- •Late closure
- •Retinal burn
- •Aphakia and pseudophakia with pupillary block
- •LASER IRIDOPLASTY (GONIOPLASTY)
- •PLATEAU IRIS
- •NANOPHTHALMOS
- •LASERS IN MALIGNANT GLAUCOMA
- •REFERENCES
- •LASER TRABECULOPLASTY
- •HISTORY
- •RESULTS
- •SELECTIVE LASER TRABECULOPLASTY
- •Concept
- •Mechanism
- •Technique
- •Patient preparation
- •Procedure
- •POSTOPERATIVE TREATMENT
- •OUTCOMES
- •CONTRAINDICATIONS
- •AS INITIAL THERAPY
- •PREDICTORS OF OUTCOME
- •APHAKIC AND PSEUDOPHAKIC OPEN-ANGLE GLAUCOMA
- •COMPLICATIONS
- •Intraocular pressure elevation
- •Sustained intraocular pressure increase
- •Hyphema
- •Peripheral anterior synechiae
- •Iritis
- •Uveitis
- •EXCIMER LASER TRABECULOSTOMY
- •Concept
- •Technique
- •Outcomes
- •OTHER LASER SCLEROSTOMY TECHNIQUES
- •REFERENCES
- •CYCLOPHOTOCOAGULATION
- •OTHER LASER PROCEDURES
- •SEVERING OF SUTURES
- •REOPENING FAILED FILTRATION SITES
- •CYCLODIALYSIS AND LASER
- •LASER SYNECHIALYSIS
- •GONIOPHOTOCOAGULATION
- •PHOTOMYDRIASIS (PUPILLOPLASTY)
- •REFERENCES
- •General surgical care
- •THE SURGICAL DECISION
- •PREOPERATIVE CARE
- •INSTRUCTIONS TO THE PATIENT
- •OUTPATIENT VERSUS INPATIENT SURGERY
- •PREOPERATIVE MEDICATIONS
- •OPERATIVE CARE
- •THE OPERATING ROOM
- •ANESTHESIA
- •EQUIPMENT
- •POSTOPERATIVE CARE
- •ACTIVITY
- •MEDICATIONS
- •REFERENCES
- •Glaucoma outflow procedures
- •GENERAL CONSIDERATIONS
- •EXTERNAL FILTRATION SURGERY
- •GUARDED PROCEDURES
- •FULL-THICKNESS PROCEDURES
- •RESULTS OF EXTERNAL FILTRATION SURGERY
- •THE CONJUNCTIVAL FLAP
- •LIMBUS-BASED FLAP
- •FORNIX-BASED FLAP
- •EXCISION OF TENON’S CAPSULE
- •GUARDED FILTRATION PROCEDURE
- •TRABECULECTOMY
- •Indications
- •Standard technique
- •Moorfields Safer Surgery System technique
- •Results
- •Surgical options and modifications
- •Triangular versus rectangular flap
- •Postoperative lasering, adjustment, or release of sutures
- •Wound-healing retardants
- •FULL-THICKNESS FILTRATION PROCEDURES
- •THERMAL SCLEROSTOMY (SCHEIE PROCEDURE)
- •SCLERECTOMY
- •Posterior lip sclerectomy
- •Anterior lip sclerectomy
- •TREPHINATION
- •IRIDENCLEISIS
- •GLAUCOMA DRAINAGE DEVICES
- •THE MOLTENO IMPLANT
- •Techniques
- •SCHOCKET PROCEDURE
- •KRUPIN VALVE AND EX-PRESS IMPLANT
- •AHMED VALVE
- •BAERVELDT IMPLANT
- •RESULTS AND COMPLICATIONS OF DRAINAGE DEVICES
- •REFERENCES
- •CATARACT SURGERY IN THE GLAUCOMATOUS EYE
- •TYPES OF GLAUCOMA AND THEIR INFLUENCE ON CATARACT MANAGEMENT
- •SELECTING THE APPROPRIATE SURGICAL APPROACH
- •SELECTING THE APPROPRIATE PROCEDURE: HISTORICAL CONSIDERATIONS
- •SURGICAL TECHNIQUES FOR COMBINED PROCEDURES
- •GENERAL PREOPERATIVE CONSIDERATIONS
- •SMALL-INCISION COMBINED SURGERY
- •Incision sites
- •Fornix versus limbal conjunctival flap
- •Scleral flap
- •Antimetabolite use
- •Managing the small pupil
- •Phacoemulsification techniques
- •Intraocular lens selection
- •Trabeculectomy formation
- •Flap closure
- •Postoperative medical management
- •EXTRACAPSULAR CATARACT EXTRACTION COMBINED SURGERY
- •Miotic pupil
- •Incision construction
- •CATARACT SURGERY WITH PRE-EXISTING FILTRATION BLEB
- •REFERENCES
- •BUTTONHOLING THE CONJUNCTIVA
- •THE SHALLOW AND FLAT ANTERIOR CHAMBER
- •FLAT ANTERIOR CHAMBER WITH HYPOTONY
- •FLAT ANTERIOR CHAMBER IN NORMOTENSIVE AND HYPERTENSIVE EYES
- •CILIARY BLOCK (MALIGNANT GLAUCOMA)
- •SUPRACHOROIDAL HEMORRHAGE (SCH)
- •INTRAOPERATIVE FLAT ANTERIOR CHAMBER
- •HYPHEMA
- •LARGE HYPHEMA
- •INTRAOCULAR INFECTION
- •SYMPATHETIC OPHTHALMIA
- •FILTRATION FAILURE
- •DIGITAL PRESSURE
- •FAILURE DURING THE FIRST POSTOPERATIVE WEEK
- •PLUGGED SCLEROSTOMY SITE
- •RETAINED VISCOELASTIC MATERIAL
- •TIGHT SCLERAL FLAP: RELEASABLE SUTURES AND LASER SUTURE LYSIS
- •INADEQUATE OPENING OF DESCEMET’S MEMBRANE
- •ENCAPSULATED BLEB
- •REOPERATION AFTER FAILED FILTRATION
- •REVISION OF ENCYSTED BLEB
- •Needling of failed blebs
- •Slit-lamp or minor surgery setting
- •Operating room setting
- •FAILED FILTRATION WITH NO BLEB
- •BLEB COMPLICATIONS AND MANAGEMENT
- •THIN-WALLED BLEBS
- •DIFFUSE BLEBS
- •OVERFUNCTIONING BLEBS
- •DELLEN
- •HYPOTONOUS MACULOPATHY
- •LATE HYPOTONY AFTER FILTERING SURGERY
- •HYPOTONY WITH OCCULT FILTERING ‘BLEB’
- •HYPOTONY WITH OCCULT CYCLODIALYSIS CLEFTS
- •HYPOTONY WITH AQUEOUS SUPPRESSION THERAPY IN CONTRALATERAL EYE
- •HYPOTONY FROM RETINAL DETACHMENT
- •HYPOTONY FROM IRITIS OR ISCHEMIA
- •REFERENCES
- •SURGERY FOR INFANTILE AND JUVENILE GLAUCOMA
- •GONIOTOMY
- •Preoperative considerations
- •Intraoperative procedures
- •Complications
- •Practice goniotomy
- •Other ab-interno angle surgery
- •TRABECULOTOMY AB EXTERNO
- •EVALUATION OF GONIOTOMY AND TRABECULOTOMY
- •COMBINED TRABECULOTOMY AND TRABECULECTOMY
- •TRABECULODIALYSIS
- •MISCELLANEOUS PROCEDURES
- •Goniosynechialysis
- •Cyclocryotherapy
- •Retrobulbar alcohol injection
- •Earlier procedures
- •REFERENCES
- •New ideas in glaucoma surgery
- •INTRODUCTION
- •NON-PENETRATING GLAUCOMA SURGERY
- •VISCOCANALOSTOMY
- •BYPASS INTRASCLERAL CHANNELS (NON-PENETRATING DEEP SCLERECTOMY)
- •SHUNTS INTO SCHLEMM’S CANAL
- •TRABECTOME®
- •SHUNTS INTO THE SUPRACHOROIDAL SPACE
- •SUMMARY
- •REFERENCES
- •Challenges for the new century
- •PATHOPHYSIOLOGY
- •CLASSIFICATION AND DIAGNOSIS
- •SCREENING
- •TREATMENT
- •CONCLUSION
- •REFERENCES
- •Appendix
- •GLAUCOMA CONSENSUS
- •GLAUCOMA DIAGNOSIS – STRUCTURE AND FUNCTION (2004)
- •CONSENSUS STATEMENTS
- •Structure
- •Function
- •Function and structure
- •GLAUCOMA SURGERY – OPEN ANGLE GLAUCOMA (2005)
- •CONSENSUS STATEMENTS
- •Indications for glaucoma surgery
- •Argon laser trabeculoplasty
- •Wound healing
- •Trabeculectomy
- •Combined cataract/trabeculectomy
- •Aqueous shunting procedures with glaucoma drainage devices
- •Comparison of procedures: trabeculectomy versus aqueous shunting procedures with glaucoma drainage devices
- •Non-penetrating glaucoma drainage surgery
- •Comparison of trabeculectomy with non-penetrating drainage glaucoma surgery in open-angle glaucoma
- •Cyclodestruction
- •Comparison of cyclophotocoagulation and glaucoma drainage device implantation
- •ANGLE CLOSURE AND ANGLE-CLOSURE GLAUCOMA (2006)
- •CONSENSUS STATEMENTS
- •Management of acute angle closure crisis
- •Surgical management of primary angle-closure glaucoma
- •Laser and medical treatment of primary angle-closure glaucoma
- •Laser and medical treatment of primary angle-closure glaucoma
- •Detection of primary angle closure and angle-closure glaucoma
- •INTRAOCULAR PRESSURE (2007)
- •CONSENSUS STATEMENTS
- •Measurement of intraocular pressure
- •Intraocular pressure as a risk factor for glaucoma development & progression
- •Epidemiology of intraocular pressure
- •Clinical trials and intraocular pressure
- •Target intraocular pressure in clinical practice
- •Index
|
chapter |
Complications and failure of filtering surgery |
36 |
|
|
References
1. Higashide T,Tagawa S, Sugiyama K: Intraoperative Healon5 injection into blebs for small conjunctival breaks created during trabeculectomy, J Cataract Refract Surg 31:1279, 2005.
2. van Buskirk E:Assessment and management
of filtering blebs. In: Mills R,Weinreb R, editors: Glaucoma surgical skills: ophthalmology
monographs 4, San Francisco,American Academy of Ophthalmology, 1991.
3. O’Connor DJ, et al:A surgical method to repair leaking filtering blebs, Ophthalmic Surg 23:336, 1992.
4. Iliff CE: Flap perforation in glaucoma surgery sealed by a tissue patch,Arch Ophthalmol 71:215, 1964.
5. Herschler J: Long-term results of trabeculectomy with collagen sponge implant containing low-dose antimetabolites, Ophthalmology 99:666, 1992.
6. Smith MF, et al: Results of intraoperative 5-fluorouracil supplementation on trabeculectomy for open-angle glaucoma,Am J Ophthalmol 114:737, 1992.
7. Lieberman M: Complications of glaucoma surgery. In: Charlton J,Weinstein G, editors: Ophthalmic surgery complications, Philadelphia, LippincottRaven, 1995.
8. Belyea DA, et al: Midterm follow-up results of combined phacoemulsification, lens implantation, and mitomycin-C trabeculectomy procedure, J Glaucoma 6:90, 1997.
9. Matsuo H, et al: Late-onset transconjunctival oozing and point leak of aqueous humor from filtering bleb
after trabeculectomy,Am J Ophthalmol 133:456, 2002.
10.Hu CY, et al: Clinical characteristics and leakage of functioning blebs after trabeculectomy with mitomycin-C in primary glaucoma patients, Ophthalmology 110:345, 2003.
11.Poulsen EJ,Allingham RR: Characteristics and risk factors of infections after glaucoma filtering surgery, J Glaucoma 9:438, 2000.
12.Spaeth GL: Complications of glaucoma surgery. In: Spaeth GL, editor: Ophthalmic surgery: principles & practice, 2nd edition, Philadelphia,WB Saunders, 1990.
13.Spaeth GL: Flat anterior chamber. In: Sherwood MB, Spaeth GL, editors: Complications of glaucoma surgery,Thorofare, NJ, Slack, 1990.
14.Migdal C, Hitchings R: Morbidity following prolonged postoperative hypotony after trabeculectomy, Ophthalmic Surg 19:865, 1988.
15.Miller E, Caprioti J:The basis for surgical treatment of open-angle glaucoma. In: Caprioli J, editor: Contemporary issues in glaucoma, Philadelphia,WB Saunders, 1991.
16.Bellows AR, Chylack LT, Hutchinson BT: Choroidal detachment, Ophthalmology 88:1107, 1981.
17.Brubaker RF, Pederson JE: Choroidal detachment, Surv Ophthalmol 27:281, 1983.
18.Burney EN, Quigley HA, Robin AL: Hypotony and choroidal detachment as late complications of trabeculectomy,Am J Ophthalmol 103:685, 1987.
19.Katz LJ: Ciliochoroidal detachment, Ophthalmic Surg 18:175, 1987.
20.Mills KB:Trabeculectomy: a retrospective long-term follow-up of 444 cases, Br J Ophthalmol 65:790, 1981.
21.Jampel HD, et al: Perioperative complications of trabeculectomy in the Collaborative Initial Glaucoma Treatment Study (CIGTS),Am J Ophthalmol 140:16, 2005.
22.Edmunds B, et al:The National Survey of Trabeculectomy. III. Early and late complications, Eye 16:297, 2002.
23.Liebmann J, et al: Management of chronic hypotony after glaucoma filtration surgery, J Glaucoma 5:210, 1996.
24.Fourman S: Management of cornea-lens touch after filtering surgery for glaucoma, Ophthalmology 97:424, 1990.
25.Hill RA, et al: Use of a symblepharon ring for treatment of over-filtration and leaking blebs after glaucoma filtration surgery, Ophthalmic Surg 21:707, 1990.
26.Melamed S, et al:The use of glaucoma shell tamponade in leaking filtration blebs,Arch Ophthalmol 104:201, 1986.
27.Ruderman JM,Allen RC: Simmon’s tamponade shell for leaking filtration blebs,Arch Ophthalmol 103:1708, 1985.
28.Spurny RC, et al: Shell tamponade technique. In: Thomas JV, Belcher CD, Simmons RJ, editors: Glaucoma surgery, St Louis, Mosby, 1992.
29.Zalta AH,Wider RH: Closure of leaking filtering blebs with cyanoacrylate tissue adhesive, Br J Ophthalmol 75:170, 1991.
30.Fiore PM, et al:The effect of anterior chamber depth on endothelial cell count after filtration surgery,Arch Ophthalmol 107:1609, 1989.
31.Smith DL, et al:The effect of glaucoma filtering surgery on corneal endothelial cell density, Ophthalmic Surg 22:251, 1991.
32.Hoskins HD Jr, Migliazzo C: Filtering surgery for glaucoma. Focal points 1986: clinical modules for ophthalmologists, vol 4, module 9, San Francisco, American Academy of Ophthalmology, 1986.
33.Spurny RC,Thomas JV: Choroidal tap and anterior chamber re-formation. In:Thomas JV, Belcher CD, Simmons RJ, editors: Glaucoma surgery, St Louis, Mosby, 1992.
34.Dellaporta A: Scleral trephination for subchoroidal effusion,Arch Ophthalmol 101:1917, 1983.
35.Wu Dunn D, Ryser D, Cantor LB: Surgical drainage of choroidal effusions following glaucoma surgery, J Glaucoma 14:103, 2005.
36.Lieberman MF, Lee DA: Diagnosis and management of malignant glaucoma. In: Higginbotham EJ,
Lee DA, editors: Clinical guide to glaucoma management,Woburn, MA, Butterworth Heinemann/Elsevier, 2004.
37.Fourman S:Angle-closure glaucoma complicating ciliochoroidal detachment, Ophthalmology 96:646, 1989.
38.Luntz MH, Rosenblatt M: Malignant glaucoma, Surv Ophthalmol 32:73, 1987.
39.Trope GE, et al: Malignant glaucoma: clinical and ultrasound biomicroscopic features, Ophthalmology 101:1030, 1994.
40.Shrader CE, et al: Pupillary and iridovitreal block in pseudophakic eyes, Ophthalmology 91:831, 1984.
41.Karim F, et al: Mechanisms of pupillary block (in reply),Arch Ophthalmol 106:167, 1988.
42.Epstein DL, et al: Experimental perfusions through the anterior and vitreous chambers with possible relationships to malignant glaucoma,Am J Ophthalmol 88:1078, 1979.
43.Quigley HA: Malignant glaucoma and fluid flow rate, Am J Ophthalmol 89:879, 1980.
44.Quigley HA, Friedman DS, Congdon NG: Possible mechanisms of primary angle-closure and malignant glaucoma, J Glaucoma 12:167, 2003.
45.Yaqub M, et al: Malignant glaucoma. In: El Sayyad F, et al, editors:The refractory glaucomas, NewYork, Igaku-Shoin, 1995.
46.Simmons RJ,Thomas JV: Surgical therapy of malignant glaucoma. In:Thomas JV, Belcher CD, Simmons RJ, editors: Glaucoma surgery, St Louis, Mosby, 1992.
47.Lynch MG, et al: Surgical vitrectomy for pseudophakic malignant glaucoma,Am J Ophthalmol 102:149, 1986.
48.Epstein DL, et al: Neodymium-YAG laser therapy to the anterior hyaloid in aphakic malignant (ciliovitreal block) glaucoma,Am J Ophthalmol 98:137, 1984.
49.Halkias A, et al: Ciliary block (malignant) glaucoma after cataract extraction with lens implant
treated withYAG laser capsulotomy and anterior hyaloidotomy, Br J Ophthalmol 76:569, 1992.
50.Chu T: Expulsive and delayed suprachoroidal hemorrhage. In: Charlton J,Weinstein G, editors: Ophthalmic surgery complications, Philadelphia, Lippincott-Raven, 1995.
51.Brubaker RF: Intraocular surgery and choroidal hemorrhage,Arch Ophthalmol 102:1753, 1984.
52.Cantor LB, Katz JL, Spaeth GL: Complications of surgery in glaucoma: suprachoroidal expulsive
hemorrhage in glaucoma patients undergoing intraocular surgery, Ophthalmology 92:1266, 1985.
53.Frenkel REP, Shin DH: Prevention and management of delayed suprachoroidal hemorrhage after filtration surgery,Arch Ophthalmol 104:1459, 1986.
54.Givens K, Shields MB: Suprachoroidal hemorrhage after glaucoma filtering surgery,Am J Ophthalmol 103:689, 1987.
55.Gressel MG, Parrish RK II, Heuer DK: Delayed non-expulsive suprachoroidal hemorrhage,Arch Ophthalmol 102:1757, 1984.
56.Ruderman JM, Harbin TS, Campbell DG: Postoperative suprachoroidal hemorrhage following filtration procedures,Arch Ophthalmol 104:210, 1986.
57.Wheeler TM, Zimmerman TJ: Expulsive choroidal hemorrhage in the glaucoma patient,Ann Ophthalmol 19:165, 1987.
58.Maumenee AE:Acute intraoperative choroidal effusion,Am J Ophthalmol 100:147, 1985.
59.Tuli SS, et al: Delayed suprachoroidal hemorrhage after glaucoma filtration procedures, Ophthalmology 108:1808, 2001.
60.Fluorouracil Filtering Surgery Study Group: Risk factors for suprachoroidal hemorrhage after filtering surgery,Am J Ophthalmol 113:501, 1992.
61.Speaker MG, et al:A case-control study of risk factors for intraoperative suprachoroidal expulsive hemorrhage, Ophthalmology 98:202, 1991.
62.Spaeth GL: Suprachoroidal hemorrhage: no longer a disaster, Ophthalmic Surg 18:329, 1987.
63.Abrams GW, et al: Management of postoperative suprachoroidal hemorrhage with continuous infusion air pump,Arch Ophthalmol 104:1455, 1986.
64.Davison JA:Vitrectomy and fluid infusion in the treatment of delayed suprachoroidal hemorrhage after combined cataract and glaucoma filtration surgery, Ophthalmic Surg 18:334, 1987.
65.Franks WA, Hitchings RA: Injection of perfluoropropane gas to prevent hypotony in eyes undergoing tube implant surgery, Ophthalmology 97:899, 1990.
66.Reynolds MG, et al: Suprachoroidal hemorrhage: clinical features and results of secondary surgical management, Ophthalmology 100:460, 1993.
67.Shihab ZM, Kristan RW: Recurrent intraoperative choroidal effusion in Sturge-Weber syndrome,
J Pediatr Strabismus 20:250, 1983.
68.Bellows AR, et al: Choroidal effusion during glaucoma surgery in patients with prominent episcleral vessels,Arch Ophthalmol 97:493, 1979.
69.Hoskins HD Jr, Hetherington J, Shaffer RN: Developmental glaucoma: therapy, Proceedings of New Orleans Academy Ophthalmology Glaucoma Symposium, St Louis, Mosby, 1980.
70.Cobb CJ, et al:The effect of aspirin and warfarin therapy in trabeculectomy, Eye 21:598, 2006. Epub Mar 3, 2006.
71.Tuli SS, et al: Delayed suprachoroidal hemorrhage after glaucoma filtration procedures, Ophthalmology 108:1808, 2001.
72.Szymanski A: Sclerectomy under a clot in surgical treatment of glaucoma, Mater Med Pol 19:278, 1987.
73.Richards DW: Intracameral tissue plasminogen activator to treat blocked glaucoma implants, Ophthalmic Surg 24:854, 1993.
74.Piltz JR, Starita RJ:The use of subconjunctivally administered tissue plasminogen activator after trabeculectomy, Ophthalmic Surg 25:51, 1994.
75.Lundy DC, et al: Intracameral tissue plasminogen activator after glaucoma surgery: indications, effectiveness, and complications, Ophthalmology 103:274, 1996.
76.WuDunn D: Intracameral urokinase for dissolution of fibrin or blood clots after glaucoma surgery,Am J Ophthalmol 124:693, 1997.
77.Diddie KR, Dinsmore S, Murphree AL:Total hyphema evacuation by vitrectomy instrumentation, Ophthalmology 188:917, 1981.
78.Belcher CD III, Brown SV, Simmons RJ:Anterior chamber washout for traumatic hyphema, Ophthalmic Surg 16:475, 1985.
529
part
8 surgical principles and procedures
79. Bellows AR, McCulley JP: Endophthalmitis in aphakic patients with unplanned filtering blebs wearing contact lenses, Ophthalmology 88:839, 1981.
80. Christensen L, Robinson PJ: Late infection of filtration blebs,Trans Pacific Coast Oto-ophthalmol Soc 44:95, 1963.
81. Freedman J, Gupta M, Bunke A: Endophthalmitis after trabeculectomy,Arch Ophthalmol 96:1017, 1978.
82. Hattenhauer JM, Lipsich MP: Late endophthalmitis after filtering surgery,Am J Ophthalmol 72:1097, 1971.
83. Wolner B, et al: Late bleb-related endophthalmitis after trabeculectomy with adjunctive 5-fluorouracil, Ophthalmology 98:1053, 1991.
84. Phillips WB, et al: Late onset endophthalmitis associated with filtering blebs, Ophthalmic Surg 25:88, 1994.
85. Burchfield JC, et al: Endophthalmitis following trabeculectomy with releasable sutures (letter),Arch Ophthalmol 114:766, 1996.
86. Greenfield DS, et al: Endophthalmitis after filtering surgery with mitomycin,Arch Ophthalmol 114:943, 1996.
87. Rosenberg LF, Siegfried CJ: Endophthalmitis associated with a releasable suture (letter),Arch Ophthalmol 114:767, 1996.
88. Jampel HD, et al: Risk factors for late-onset infection following glaucoma filtration surgery, Arch Ophthalmol 119:1001, 2001.
89. Lehmann OJ, et al: Risk factors for development
of post-trabeculectomy endophthalmitis, Br J Ophthalmol 84:1349, 2000.
90. Katz LJ: Endophthalmitis. In: Sherwood MB, Spaeth GL, editors: Complications of glaucoma surgery, Thorofare, NJ, Slack, 1990.
91. Ticho U, Ophir A: Late complications after glaucoma filtering surgery with adjunctive 5- fluorouracil,Am J Ophthalmol 115:506, 1993.
92. Higginbotham EJ, et al: Bleb-related endophthalmitis after trabeculectomy with mitomycin C, Ophthalmology 103:650, 1996.
93. Parris R, Minckler D: Late endophthalmitis: filtering surgery time bomb (editorial)?, Ophthalmology 103:1167, 1996.
94. De Bry PW, et al: Incidence of late-onset blebrelated complications following trabeculectomy with mitomycin,Arch Ophthalmol 120:297, 2000.
95. Busbee BG, et al: Bleb-associated endophthalmitis: clinical characteristics and visual outcomes, Ophthalmology 111:1495, 2004.
96. Ashkenazi I, et al: Risk factors associated with late infection of filtering blebs and endophthalmitis, Ophthalmic Surg 22:570, 1991.
97. Ciulla TA, et al: Blebitis, early endophthalmitis,
and late endophthalmitis after glaucoma-filtering surgery, Ophthalmology 104:986, 1996.
98. Chen PP, et al: Outpatient treatment of bleb infection,Arch Ophthalmol 115:1124, 1997.
99. Brown RH, et al:Treatment of bleb infection after glaucoma surgery,Arch Ophthalmol 112:57,
1994.
100.Kangas TA, et al: Delayed-onset endophthalmitis associated with conjunctival filtering blebs, Ophthalmology 104:746, 1997.
101.Poulsen EJ,Allingham RR: Characteristics and risk factors of infections after glaucoma filtering surgery, J Glaucoma 9:438, 2000.
102.Dhaliwal R, Meredith T: Endophthalmitis. In: Charlton J,Weinstein G, editors: Ophthalmic surgery complications, Philadelphia, LippincottRaven, 1995.
103.Olson RJ: Reducing the risk of postoperative endophthalmitis, Surv Ophthalmol 49(suppl):S55, 2004.
104.Vote BJ, et al: Changing trends in sympathetic ophthalmia, Clin Exp Ophthalmol (Aus) 32:542, 2004.
105.El-Asrar AM,Al-Obeidan SA: Sympathetic ophthalmia after complicated cataract surgery and intraocular lens implantation, Eur J Ophthalmol 11:193, 2001.
106.Edward DP, et al: Sympathetic ophthalmia following neodymium:YAG cyclotherapy, Ophthalmic Surg 20:544, 1989.
107.Brown SV, et al: Sympathetic ophthalmia following Nd:YAG cyclotherapy (letter), Ophthalmic Surg 21:736, 1990.
108.Lam S: High incidence of sympathetic ophthalmia after contact and noncontact neodymium:YAG cyclotherapy, Ophthalmology 99:1818, 1992.
109.Harrison TJ: Sympathetic ophthalmia after cyclocryotherapy of neovascular glaucoma without ocular penetration, Ophthalmic Surg 24:44, 1993.
110.Singh G: Sympathetic ophthalmia after Nd:YAG cyclotherapy (letter; comment), Ophthalmology 100:798, 1993.
111.Bechrakis NE, et al: Sympathetic ophthalmia following laser cyclocoagulation,Arch Ophthalmol 112:80, 1994.
112.Damico F, Kiss S,Young L: Sympathetic ophthalmia, Semin Ophthalmol 20:191, 2005.
113.Henderer JD, et al:A randomized trial of the longterm effects of digital ocular compression in the late postoperative period, J Glaucoma 10:266, 2001.
114.Traverso CE, et al: Focal pressure: a new method to encourage filtration after trabeculectomy, Ophthalmic Surg 15:62, 1984.
115.Wells AP, Bunce C, Khaw PT: Flap and suture manipulation after trabeculectomy with adjustable sutures: titration of flow and intraocular pressure in guarded filtration surgery, J Glaucoma 13:400, 2004.
116.Kane H, et al: Response of filtered eyes to digital ocular pressure, Ophthalmology 104:202, 1997.
117.MacRae SM,Van Buskirk EM: Late wound dehiscence after penetrating keratoplasty in association with digital massage,Am J Ophthalmol 102:391, 1986.
118.van Buskirk EM: Reopening filtration sites with the argon laser,Am J Ophthalmol 94:1, 1982.
119.Ticho U, Ivry M: Reopening of occluded filtering blebs by argon laser photocoagulation,Am J Ophthalmol 84:413, 1977.
120.Kurata F, et al: Reopening filtration fistulas with transconjunctival argon laser photocoagulation,Am J Ophthalmol 98:340, 1984.
121.Dailey RA, et al: Reopening filtration fistulas with the neodymium-YAG laser,Am J Ophthalmol 102:491, 1986.
122.Cohn HC, et al:YAG laser treatment in a series of failed trabeculectomies,Am J Ophthalmol 108:395, 1989.
123.Rankin GA, Latina MA:Transconjunctival Nd:YAG laser revision of failing trabeculectomy, Ophthalmic Surg 21:365, 1990.
124.Latina MA, Rankin GA: Internal and transconjunctival neodymium:YAG laser revision of late failing filters, Ophthalmology 98:215, 1991.
125.Wilson RP, Lloyd J:The place of sodium hyaluronate in glaucoma surgery, Ophthalmic Surg 17:30, 1986.
126.Glasser DB, Matsuda M, Edelhauser HF:A comparison of the efficacy and toxicity of and intraocular pressure response to viscous solutions in the anterior chamber, Arch Ophthalmol 104:1819, 1986.
127.Anmarkrud N, et al:A comparison of Healon and Amvisc on the early postoperative pressure after extracapsular cataract extraction with implantation of posterior chamber lens,Acta Ophthalmol Scand 74:626, 1996.
128.Henry JC, Olander K: Comparison of the effect of four viscoelastic agents on early postoperative
intraocular pressure, J Cataract Refract Surg 22:960, 1996.
129.Hutz WW, et al: Comparison of viscoelastic substances used in phacoemulsification, J Cataract Refract Surg 22:955, 1996.
130.Kanellopoulos AJ, et al: Comparison of topical timolol gel to oral acetazolamide in the prophylaxis of viscoelastic-induced ocular hypertension after penetrating keratoplasty, Cornea 16:12, 1997.
131.Vesti E, Raitta C:A review of the outcome of trabeculectomy in open-angle glaucoma, Ophthalmic Surg Lasers 28:128, 1997.
132.Kapetansky FM: Laser suture lysis after trabeculectomy, J Glaucoma 12:316, 2003.
133.Kolker AE, et al:Trabeculectomy with releasable sutures,Trans Am Ophthalmol Soc 91:131, 1993.
134.Kolker AE, et al:Trabeculectomy with releasable sutures,Arch Ophthalmol 112:62, 1994.
135.Hsu CT,Yarng SS:A modified removable suture in trabeculectomy, Ophthalmic Surg 24:579, 1993.
136.Johnstone MA, et al:A releasable scleral-flap tamponade suture for guarded filtration surgery, Arch Ophthalmol 111:398, 1993.
137.Maberley D, et al: Releasable ‘U’ suture for trabeculectomy surgery, Ophthalmic Surg 25:251, 1994.
138.Khaw PT, Dahlman A, Mireskandari K: Trabeculectomy technique, Glaucoma Today 3:22,
2005.
138b. Stalmans I, Gillis A, Lafaut AS, Zeyan T: Safe trabeculectomy technique: long term outcome. Br J Ophthalmol 90:p 44–7, 2006.
139.Lieberman MF: Suture lysis by laser and goniolens (letter),Am J Ophthalmol 95:257, 1983.
140.Hoskins H Jr, Migliazzo C: Management of failing filtering blebs with the argon laser, Ophthalmic Surg 15:731, 1984.
141.Tomey KF:A simple device for laser suture lysis after trabeculectomy (letter),Arch Ophthalmol 109:14, 1991.
142.Mandelkorn RM, et al:A new argon laser suture lysis lens (letter), Ophthalmic Surg 25:480, 1994.
143.Ritch R:A new lens for argon laser suture lysis, Ophthalmic Surg 25:126, 1994.
144.Temel A, Sayin I:An inexpensive visualization method for laser suture lysis (letter),Arch Ophthalmol 114:1301, 1996.
145.Lieberman MF: Diode laser suture lysis following trabeculectomy with mitomycin (letter),Arch Ophthalmol 114:364, 1996.
146.Asamoto A, et al:A retrospective study of the effects of laser suture lysis on the long-term results of trabeculectomy, Ophthalmic Surg 26:223, 1995.
147.van Buskirk EM: Cysts of Tenon’s capsule following filtration surgery,Am J Ophthalmol 94:522, 1982.
148.Pederson JE, Smith SG: Surgical management of encapsulated filtering blebs, Ophthalmology 92:955, 1985.
149.Sherwood MB, et al: Cysts of Tenon’s capsule following filtration surgery: medical management, Arch Ophthalmol 105:1517, 1987.
150.Richter CU, et al:The development of encapsulated filtering blebs, Ophthalmology 95:1163, 1988.
151.Ophir A: Encapsulated filtering bleb,A selective review: new deductions. Eye, 6:348, 1992.
152.Ophir A,Ticho U: Encapsulated filtering bleb and subconjunctival 5-fluorouracil, Ophthalmic Surg 23:339, 1992.
153.CostaVP, et al: Needling versus medical treatment in encapsulated blebs: a randomized, prospective study, Ophthalmology 104:1215, 1992.
154.Feyi-Waboso A, Ejere HO: Needling for encapsulated trabeculectomy filtering blebs, Cochrane Database Syst Rev(Issue 2), 2004. Art. No.: CD003658. DOI: 10.1002/14651858. CD003658.pub2.
155.Yarangumeli A, Koz OG, Kural G: Encapsulated blebs following primary standard trabeculectomy: course and treatment, J Glaucoma 13:251, 2004.
156.Scott DR, Quigley HA: Medical management of a high bleb phase after trabeculectomies, Ophthalmology 95:1169, 1988.
157.Kurata F, Krupin T, Kolker AE: Reopening filtration fistulas with transconjunctival argon laser photocoagulation,Am J Ophthalmol 98:340, 1984.
158.Fankhauser F:Wound healing in glaucoma filtering surgery,Amsterdam/NewYork, Kugler Publications, 1992.
159.Starita RJ, et al: Shortand long-term effects of postoperative corticosteroids on trabeculectomy,
Ophthalmology 92:938, 1985.
159b. Rotchford AP, King AJW: Needling revision of trabeculectomies. Bleb morphology and long-term survival. Ophthalmology 115:1148–1153, 2008.
160.Cohen JS, et al: Revision of filtration surgery,Arch Ophthalmol 95:1612, 1977.
161.Gillies WE, Brooks AM: Restoring the function of the failed bleb,Aust N Z J Ophthalmol 19:49, 1991.
530
|
chapter |
Complications and failure of filtering surgery |
36 |
|
|
162.Iwach AG, et al:Transconjunctival mitomycin- C in needle revisions of failing filtering blebs, Ophthalmology 110:734, 2003.
163.Suzuki R, et al: Long-term follow-up of initially successful trabeculectomy with 5-fluorouracil injections, Ophthalmology 109:1921, 2002.
164.Ewing RH, Stamper RL: Needle revision with and without 5-fluorouracil for the treatment of failed filtering blebs,Am J Ophthalmol 110:254, 1990.
165.Mardelli PG, et al: Slit-lamp needle revision of failed filtering blebs using mitomycin C, Ophthalmology 103:1946, 1996.
166.Lieberman MF, Ewing RH: Drainage implant surgery for refractory glaucoma, Int Ophthalmol Clin 30:198, 1990.
167.Kanski JJ:Treatment of late endophthalmitis associated with filtering blebs,Arch Ophthalmol 91:339, 1974.
168.Belyea DA: Late onset of sequential multifocal leaks after glaucoma filtration surgery with 5- fluorouracil and mitomycin C,Arch Ophthalmol 124:40, 1997.
169.Hennis HL, Stewart WC: Use of the argon laser to close filtering bleb leaks, Graefes Arch Clin Exp Ophthalmol 230:537, 1992.
170.Kosmin AS,Wishart PK:A full-thickness scleral graft for the surgical management of a late filtration bleb leak, Ophthalmic Surg Lasers 28:461, 1997.
171.Hughes BA, et al: Use of fascia lata in revision of filtration surgery, J Glaucoma 5:207, 1996.
172.Hara T, Shirato S: Surgical revision of failed filtering bleb with mitomycin C, Nippon Ganka Gakkai Zasshi 101:516, 1997.
173.La Borwit SE, Quigley HA, Jampel HD: Bleb reduction and bleb repair after trabeculectomy, Ophthalmology 107:712, 2000.
174.McMillan JJ, Mead MD: Prophylactic subconjunctival antibiotics after cataract extraction; evaluation of their desirability and efficacy, Int Ophthalmol Clin 34:43, 1994.
175.Starr M, Lally JM:Antimicrobial prophylaxis for ophthalmic surgery, Surv Ophthalmol 39:485, 1995.
176.Kownacki JJ: Prophylactic antibiotics in ophthalmic surgery (letter), Surv Ophthalmol 41:503, 1997.
177.Starr M, Lally JM: Response to Kownacki’s letter re: prophylactic antibiotics in ophthalmic surgery, Surv Ophthalmol 41:504, 1997.
178.Tabbara KF: Late infections following filtering procedures,Ann Ophthalmol 8:1228, 1976.
179.Scheie HG, Guehl JJ: Surgical management of overhanging blebs after filtering procedures,Arch Ophthalmol 94:325, 1979.
180.Sun R, Gimbel HV: Effects of topical ketorolac and diclofenac on normal corneal sensation, J Refract Surg 13:158, 1997.
181.Ulrich GG, et al: Clinicopathologic features and surgical management of dissecting glaucoma filtering blebs, Ophthalmic Surg Lasers 28:151, 1997.
182.Teng CC, Chi HH, Katzin HM: Histology and mechanism of filtering operations,Am J Ophthalmol 47:16, 1959.
183.Cleasby G, et al: Cryosurgical closure of filtering blebs,Arch Ophthalmol 84:319, 1972.
184.Kirk H: Cauterization of filtering blebs following cataract extraction,Trans Am Acad Ophthalmol Otolaryngol 77:573, 1973.
185.Fink AJ, et al: Management of large filtering blebs with the argon laser,Am J Ophthalmol 101:695, 1986.
186.Gehring J, Ciccarelli E:Trichloroacetic acid treatment of filtering blebs following cataract extraction,Am J Ophthalmol 74:662, 1972.
187.Shaffer RN: Filtering procedures in open angle glaucoma, Int Ophthalmol Clin 3:141, 1983.
188.Mai G,Yang S: Relationship between corneal dellen and tearfilm breakup time,Yen Ko Hsueh Pao 7:43, 1991.
189.Soong HK, Quigley HA: Dellen associated with filtering blebs,Arch Ophthalmol 101:385, 1983.
190.Dellaporta A: Fundus changes in post-operative hypotony,Am J Ophthalmol 40:781, 1955.
191.Gass J: Hypotonous maculopathy. In: Bellows J, editor: Contemporary ophthalmology: honoring Sir Stewart Duke Elder, Baltimore,Williams & Wilkins, 1972.
192.Whiteside Michel J, et al: Initial 5-fluorouracil trabeculectomy in young patients, Ophthalmology 99:7, 1992.
193.Altan T, et al: Hypotonic maculopathy after trabeculectomy with postoperative use of 5- fluorouracil, Ophthalmologica 208:318, 1994.
194.Jampel HD, et al: Hypotony maculopathy following trabeculectomy with mitomycin-C (letter),Arch Ophthalmol 110:1049, 1992.
195.Costa,V, et al: Hypotony maculopathy following the use of topical mitomycin C in glaucoma filtration surgery, Ophthalmic Surg 24:389, 1993.
196.Zacharia P, et al: Ocular hypotony after trabeculectomy with mitomycin C,Am J Ophthalmol 116:314, 1993.
197.Detry Morel M, Kittel B: Surface-wrinkling maculopathy as a potential complication of trabeculectomy: a case report, Ophthalmic Surg 22:38, 1991.
198.Oyakhire JO, Moroi SE: Clinical and anatomical reversal of long-term hypotony maculopathy,Am J Ophthalmol 137:953, 2004.
199.Stamper RL, et al: Hypotonous maculopathy after trabeculectomy with subconjunctival 5-fluorouracil, Am J Ophthalmol 114:544, 1992.
200.Cohen SM, et al:Treatment of hypotony maculopathy after trabeculectomy, Ophthalmic Surg Lasers 26:435, 1995.
201.Kee C, Kaufman PL: Profound long-term hypotony without maculopathy after trabeculectomy with antimetabolite,Acta Ophthalmol (Copenh) 72:388, 1994.
202.Nemeth J, Horoczi Z: Changes in the ocular dimensions after trabeculectomy, Int Ophthalmol 16:355, 1992.
203.Francis BA, et al: Changes in axial length following trabeculectomy and glaucoma drainage device surgery, Br J Ophthalmol 89:17, 2005.
204.Nuyts RM, et al:Treatment of hypotonous maculopathy after trabeculectomy with mitomycin C,Am J Ophthalmol 118:322, 1994.
205.Choudhri SA, et al: Efficacy of autologous blood injection for treating overfiltering or leaking blebs after glaucoma surgery,Am J Ophthalmol 123:554, 1997.
206.Haynes WL,Alward WL: Combination of autologous blood injection and bleb compression sutures to treat hypotony maculopathy, J Glaucoma 8:384, 1999.
207.AkovaYA, et al: Management of hypotony maculopathy and a large filtering bleb after trabeculectomy with mitomycin C: success with
argon laser therapy, Ophthalmic Surg Lasers 31:491, 2000.
208.Schwartz GF, et al: Resuturing the scleral flap leads to resolution of hypotony maculopathy, J Glaucoma 5:246, 1996.
209.Funk J: Surgical revision for hypotonia after glaucoma operation with mitomycin C, Ophthalmologe 94:419, 1997.
210.Bashford KP, Shafranov G, Shields MB: Bleb revision for hypotony maculopathy after
trabeculectomy, J Glaucoma 13:256, 2004. 210b. Eha J, Hoffmann EH,Wahl J, Pfeiffer N: Flap
suture – a simple technique for the revision of hypotony maculopathy following trabeculectomy with mitomycin C. Graefes Arch Clin Exp Ophthalmol 869–874, 2008.
211.Duker JS, Schuman JS: Successful surgical treatment of hypotony maculopathy following trabeculectomy with topical mitomycin C, Ophthalmic Surg 25:463, 1994.
212.Suner IJ, et al: Hypotony maculopathy after filtering surgery with mitomycin C: incidence and treatment, Ophthalmology 104:207, 1997.
213.Schubert HD: Postsurgical hypotony: relationship to fistulization, inflammation, chorioretinal lesions, and the vitreous, Surv Ophthalmol 41:97, 1996.
214.Chandler P, Maumenee A:A major cause of hypotony,Am J Ophthalmol 52:609, 1961.
215.Ormerod LD, et al: Management of the hypotonous cyclodialysis cleft, Ophthalmology 98:1384, 1991.
216.Bauer B, et al:Argon laser photocoagulation of cyclodialysis clefts after cataract surgery,Acta Ophthalmol Scand 73:283, 1995.
217.Gentile RC, et al:Accurate diagnosis of traumatic cyclodialysis by ultrasound biomicroscopy, Ophthalmic Surg Lasers 27:92, 1996.
218.Ormerod L, et al: Cyclodialysis clefts: natural history, assessment and management. In:Weinstein G, editor: Open angle glaucoma, NewYork, Churchill-Livingstone, 1986.
219.Maffett MJ, O’Day DM: Cyclodialysis cleft following a scleral tunnel incision, Ophthalmic Surg 25:387, 1994.
220.Small EA, et al: Hypotonus cyclodialysis cleft following suture fixation of a posterior chamber intraocular lens, Ophthalmic Surg 25:107, 1994.
221.Metrikin DC, et al:Transscleral repair of recalcitrant, inadvertent, postoperative cyclodialysis cleft, Ophthalmic Surg 25:406, 1994.
222.Parnes RE, et al: Hypotonus cyclodialysis cleft following anterior chamber intraocular lens removal, Ophthalmic Surg 25:386, 1994.
223.Amini H, Razeghinejad MR:Transscleral diode laser therapy for cyclodialysis cleft induced hypotony, Clin Exp Ophthalmol (Aus) 33:348, 2005.
224.Vela MA, Campbell DG: Hypotony and ciliochoroidal detachment following pharmacologic therapy in previously filtered patients, Ophthalmology 92:50, 1985.
225.Burton T, et al: Intraocular pressure in retinal detachment, Int Ophthalmol 1:147, 1979.
226.Zarbin MA, et al: Dissection of epiciliary tissue to treat chronic hypotony after surgery for retinal detachment with proliferative vitreoretinopathy, Retina 11:208, 1991.
227.Radda T, et al:Acute ocular hypotony: a rare complication of temporal arteritis, Ophthalmologica 182:148, 1981.
531